Belzutifan is a prescription medication; the dosage, duration of treatment, and decision on whether to continue medication must be determined by a spe···【Read More】
Update: 2026-09-30Source: Haiou HealthViews: 145
Most management strategies for the adverse reactions of Belzutifan in the package insert do not provide specific home-based measures. The management m···【Read More】
Update: 2026-09-30Source: Haiou HealthViews: 146
Quizartinib is administered orally. The specific dosage is not fixed and varies over time based on the phase of treatment, electrocardiogram (ECG) res···【Read More】
Update: 2026-09-29Source: Haiou HealthViews: 166
Encorafenib may be taken with or without food, but grapefruit should be avoided; if a dose is missed, use 12 hours as the cutoff to determine whether ···【Read More】
Update: 2026-09-28Source: Haiou HealthViews: 153
Encorafenib is an oral BRAF inhibitor that inhibits tumor growth by targeting abnormally activated kinases such as BRAF V600E and blocking the RAS/RAF···【Read More】
Update: 2026-09-28Source: Haiou HealthViews: 165
The dosage and administration of encorafenib vary depending on the indication! Encorafenib is a prescription drug, and the dosage and treatment course···【Read More】
Update: 2026-09-24Source: Haiou HealthViews: 161
During Selpercatinib treatment, please complete regular re-examinations of liver function, blood pressure, electrocardiograms (ECGs), electrolytes, an···【Read More】
Update: 2026-09-23Source: Haiou HealthViews: 164
Alpelisib is typically used in combination with fulvestrant. The focus on special populations in this text covers only the Alpelisib component, includ···【Read More】
Update: 2026-09-22Source: Haiou HealthViews: 159
Before starting Alpelisib treatment, please inform your doctor in a timely manner about all medications you are currently taking to minimize potential···【Read More】
Update: 2026-09-22Source: Haiou HealthViews: 153
Selpercatinib is a highly selective RET kinase inhibitor that blocks tumor growth signaling by inhibiting abnormally activated RET proteins. Treatment···【Read More】
Update: 2026-09-21Source: Haiou HealthViews: 154
During treatment with Selpercatinib, patients should avoid or stagger the administration of acid-reducing agents (stomach medications) and St. John···【Read More】
Update: 2026-09-21Source: Haiou HealthViews: 153
During treatment, if adverse reactions such as rash, hyperglycemia, diarrhea or colitis, or other toxicities occur, the dosage should be adjusted acco···【Read More】
Update: 2026-09-20Source: Haiou HealthViews: 158
Anagrelide is an oral platelet-reducing agent that decreases platelet production by inhibiting the maturation and division of megakaryocytes in the bo···【Read More】
Update: 2026-09-18Source: Haiou HealthViews: 166
Mitotane Drug Interactions1. Hepatic Enzyme InductionMitotane is a strong hepatic enzyme inducer and may affect drugs metabolized by the liver.2. Spec···【Read More】
Update: 2026-08-07Source: Haiou HealthViews: 182
Dizziness or fatigue may occur during medication, avoid driving or operating machinery. Immediately inform your doctor in case of trauma, infection, o···【Read More】
Update: 2026-08-07Source: Haiou HealthViews: 186
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos